Inside the Game-Changer: How OncoAssure’s Bold US Move with GoPath Diagnostics Could Redefine the Future of Cancer Detection
Ever wonder what happens when cutting-edge Irish biotech innovation teams up with American diagnostic muscle? Well, wonder no more. OncoAssure, the clever medical diagnostics outfit nestled at NovaUCD in Dublin, just inked a deal with Illinois-based GoPath Diagnostics to bring their groundbreaking OncoAssure™ Prostate test exclusively to the US market. This isn’t your run-of-the-mill test—it’s a next-gen, clinically validated prognostic tool that blends genomic wizardry with solid clinical data, helping docs and patients navigate the tricky waters of localized prostate cancer with personalized, data-driven decisions right after biopsy and surgery. It’s like giving a crystal ball to urologists, predicting who’s at heightened risk for recurrence or aggressive disease with staggering accuracy. Pair that with GoPath’s nationwide sales savvy and urology expertise, and you’ve got a powerful alliance poised to shake up prostate cancer care in America. Curious how this fusion of innovation and reach could rewrite the playbook for cancer diagnostics? LEARN MORE.
OncoAssure, the NovaUCD-headquartered Irish medical diagnostics company has agreed an exclusive partnership with Illinois-based GoPath Diagnostics.
Under the agreement, GoPath will hold the exclusive rights to provide the OncoAssureTM Prostate test in the US.
OncoAssureTM Prostate is a next-generation clinically validated prognostic test designed to support clinical decision-making for men diagnosed with localised prostate cancer.
By integrating advanced genomic data with well-validated clinical variables, the test allows physicians and patients to make personalised, data-driven treatment decisions at two critical points in the prostate cancer pathway, post-biopsy and post-surgery.
Patients with a higher OncoAssureTM Prostate result were 4.4 times more likely to experience biochemical recurrence within five years compared to patients with a lower result.
Separately, patients with a higher test result were 9.7 times more likely to experience adverse pathology, associated with more aggressive cancer, compared to patients with a lower result.
This collaboration leverages GoPath’s extensive resources in the urological field and its national sales infrastructure to meet the growing demand for validated prognostic testing in the US urology segment.
“Partnering with GoPath represents an important step in expanding access to OncoAssureTM Prostate in the United States,” said Des O’Leary, CEO of OncoAssure.
“By combining our focus on clinically meaningful biomarker development with GoPath’s proven capabilities in delivering high-quality diagnostic services, we can better support clinicians with actionable insights at key decision points in prostate cancer management.”
Dr Jim Lu, CEO and medical director of GoPath Diagnostics, said: “Partnering with OncoAssure allows us to expand our prostate cancer portfolio from morphologic and molecular diagnosis, targeted immunotherapies, and germline testing, to now include a clinically validated prognostic test, OncoAssureTM Prostate, for prostate cancer patients, which is a very significant step forward.
“By combining OncoAssure’s genomic innovation with our national sales infrastructure, we are better positioned to support urologists with actionable insights across key decision points in the patient journey.”
Photo: Des O’Leary, CEO of OncoAssure. (Pic: Supplied)
Vital Essentials Freeze Dried Dog Treats | Beef Liver, Single Ingredient | Premium Quality | Grain Free Training Treats for Dogs, 2.1 oz Bag
$5.99 (as of June 10, 2026 02:25 GMT +00:00 - More infoProduct prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on [relevant Amazon Site(s), as applicable] at the time of purchase will apply to the purchase of this product.)
Core Power Elite High Protein Shake, Chocolate, 42g Bottle, 14oz, 12 Pack
$50.98 (as of June 10, 2026 02:31 GMT +00:00 - More infoProduct prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on [relevant Amazon Site(s), as applicable] at the time of purchase will apply to the purchase of this product.)
CuteBone Dog Dresses Velvet 4th of July Small Dogs Clothes Onesie Pet Apparel Girl Puppy Skirt with Bow Hair Rope
(as of June 10, 2026 02:36 GMT +00:00 - More infoProduct prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on [relevant Amazon Site(s), as applicable] at the time of purchase will apply to the purchase of this product.)
DOGWONG Girl Dog Collar for Small Dogs, Pink Checked Dog Collars, Pink Checked Dogs Collars for Small Medium Dogs, Neck 11-16 inches
(as of June 10, 2026 02:39 GMT +00:00 - More infoProduct prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on [relevant Amazon Site(s), as applicable] at the time of purchase will apply to the purchase of this product.)
Post Comment